Is mesenchymal stem cell therapy suitable for reducing insulin resistance ın fructose-induced metabolic syndrome rat model?


Öztaş Ş. B. , AKIN D., DEMİRCAN G., YAPIŞLAR H., KETENCİ S., KOLDEMİR GÜNDÜZ M. , ...Daha Fazla

1st Pharmacogenomics İstanbul Summit: Increasing the Safety and Effectivness of Personalized therapy for Metabolic Disorders, 27 - 28 Kasım 2015